Atlas Trials

Growth Hormone Deficiency in Children

25 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Growth Hormone Deficiency in Children

RecordFirmDate
A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day. (NCT04970654)Novo Nordisk A/S2021-07-22
Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA) (NCT03972345)Novo Nordisk A/S2019-06-21
A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (REAL4) (NCT03811535)Novo Nordisk A/S2019-05-20
Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy (NCT03672617)Novo Nordisk A/S2018-10-02
Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function. (NCT03212131)Novo Nordisk A/S2017-08-16
Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function (NCT03186495)Novo Nordisk A/S2017-06-20
Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency (NCT02616562)Novo Nordisk A/S2016-03-31
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD) (NCT02580032)Novo Nordisk A/S2015-10-05
A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency (NCT01973244)Novo Nordisk A/S2013-12-16
First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects (NCT01514500)Novo Nordisk A/S2012-01-16
Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone (NCT01327924)Novo Nordisk A/S2011-04-01
Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents (NCT01245374)Novo Nordisk A/S2010-11-01
An Observational Study on Treatment Compliance by Children Treated With Growth Hormone (NCT01068639)Novo Nordisk A/S2010-02-01
A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone (NCT00936403)Novo Nordisk A/S2009-08-01
Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™ (NCT01500486)Novo Nordisk A/S2007-01-01
Observational Prospective Study on Patients Treated With Norditropin® (NCT00960128)Novo Nordisk A/S2006-04-01
Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome (NCT01604161)Novo Nordisk A/S2005-05-01
Liquid Somatropin Formulation in Children With Growth Hormone Deficiency (NCT00567385)Novo Nordisk A/S2003-03-10
Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency (NCT01502124)Novo Nordisk A/S2001-05-08
Safety and Efficacy of Long-term Somatropin Treatment in Children (NCT01543867)Novo Nordisk A/S2001-01-01
Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency (NCT01563926)Novo Nordisk A/S2000-10-23
Effect of Growth Hormone in Children With Growth Hormone Deficiency (NCT00262249)Novo Nordisk A/S2000-08-01

Track Growth Hormone Deficiency in Children automatically

Every clearance here is in the API, with alerts when new ones post.